Using CRISPR/Cas9 genome editing, we were recently able to study the effects of the second hit in blood outgrowth endothelial cells (BOECs) of a CCM patient with a pathogenic CCM1 germline mutation. This evidence concerns the gene KRIT1 and cerebral cavernous malformation.